人工血管移植术后医院感染的危险因素与结局
前瞻性队列研究纳入261例人工血管移植患者,医院感染发生率为27.20%,手术部位感染最常见。手术时下肢皮肤软组织感染是各类人工血管医院感染的显著预测因素,手术部位感染与长期死亡风险最高相关。
要点
- 手术时存在下肢皮肤软组织感染显著增加医院感染风险。
- 手术部位感染是长期死亡的强预测因素(调整RR 6.35)。
- 若病情允许,应推迟手术至下肢皮肤软组织感染消退。
核心结论
- 手术部位感染是医院感染的主要类型。
- 医院感染风险主要取决于手术时下肢皮肤软组织感染的存在。
- 死亡风险由年龄、术中并发症和手术部位感染决定。
研究设计与样本
- 前瞻性队列研究,纳入2008年4月至2009年8月单中心连续261例人工血管移植患者。
- 纳入腹主动脉人工血管(伴或不伴髂股动脉受累)及外周人工血管移植患者。
- 排除年龄小于15岁及严重免疫缺陷患者,随访至术后3年或死亡。
主要发现
- 261例患者中男性230例(88.12%),平均年龄67.57岁(标准差10.82)。
- 医院感染发生71例(27.20%),其中手术部位感染42例,呼吸道感染15例,尿路感染15例。
- 42例手术部位感染中,61.9%位于下肢(14例表浅、10例深部、2例人工血管感染),38.1%位于腹部(7例表浅、7例深部、2例人工血管感染)。
- 腹主动脉人工血管医院感染的独立预测因素包括手术时活动性下肢皮肤软组织感染(调整OR 12.6,95%CI 1.15-138.19)和机械通气(调整OR 55.96,95%CI 3.9-802.39)。
- 外周人工血管医院感染的独立预测因素包括手术时活动性下肢皮肤软组织感染(调整OR 2.43,95%CI 1.08-5.47)、入院时低血红蛋白(调整OR 0.84,95%CI 0.71-0.99)和急诊手术(调整OR 4.39,95%CI 1.51-12.74)。
关键数值与推荐
- 院内死亡率为1.92%,术后第一个月生存概率为0.96。
- 死亡的显著预测因素包括活动性下肢皮肤软组织感染(调整RR 12.07,95%CI 1.04-154.75)、术后高血糖(调整RR 1.02,95%CI 1.00-1.04)和非感染性手术并发症(调整RR 19.38,95%CI 2.25-167.29)。
- 长期死亡率为11.88%,12、24、36个月生存概率分别为0.94、0.92、0.87。
- 与长期死亡显著相关的变量包括年龄较大(调整RR 1.08,95%CI 1.01-1.15)、出院时高肌酐(调整RR 1.91,95%CI 1.08-3.38)和手术部位感染(调整RR 6.35,95%CI 1.87-21.53)。
临床怎么用
- 术前应评估并处理下肢活动性皮肤软组织感染,若病情允许应推迟手术至感染消退。
- 对接受人工血管移植的患者,应关注手术部位感染预防,尤其是下肢部位。
- 术后监测血糖和肾功能,及时处理非感染性手术并发症,可能有助于降低死亡风险。
局限性
- 单中心研究,样本量有限,部分预测因素置信区间宽泛。
- 观察性设计,可能存在残余混杂。
- 结果外推需谨慎,尤其针对不同人群和中心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to determine risk factors for nosocomial infections (NIs) and predictors of mortality in patients with prosthetic vascular grafts (PVGs). METHODS: This was a prospective cohort study of all consecutive patients who underwent PVG of the abdominal aorta with or without iliac-femoral involvement and peripheral PVG from April 2008 to August 2009 at a university hospital. Patients younger than 15 years and those with severe immunodeficiency were excluded. The follow-up period was until 3 years after surgery or until death. RESULTS: There were 261 patients included; 230 (88.12%) were male, and the mean age was 67.57 (standard deviation, 10.82) years. The reason for operation was aortic aneurysm in 49 (18.77%) patients or lower limb arteriopathy in 212 (81.23%) patients. NIs occurred in 71 (27.20%) patients. Of these, 42 were surgical site infections (SSIs), of which 61.9% occurred in the lower extremities (14 superficial, 10 deep, and 2 PVG infections) and 38.1% in the abdomen (7 superficial, 7 deep, and 2 PVG infections); 15 were respiratory tract infections; and 15 were urinary tract infections. Active lower extremity skin and soft tissue infection (SSTI) at the time of surgery was a significant predictor of NI for both types of PVG (abdominal aortic PVG: adjusted odds ratio [OR], 12.6; 95% confidence interval [CI], 1.15-138.19; peripheral PVG: adjusted OR, 2.43; 95% CI, 1.08-5.47). Other independent predictors of NI were mechanical ventilation (adjusted OR, 55.96; 95% CI, 3.9-802.39) for abdominal aortic PVG and low hemoglobin levels on admission (adjusted OR, 0.84; 95% CI, 0.71-0.99) and emergent surgery (adjusted OR, 4.39; 95% CI, 1.51-12.74) for peripheral PVG. The in-hospital mortality rate was 1.92%. The probability of surviving the first month was 0.96, and significant predictors of mortality were active lower extremity SSTI (adjusted risk ratio [RR], 12.07; 95% CI, 1.04-154.75), high postsurgical glucose levels (adjusted RR, 1.02; 95% CI, 1.00-1.04), and noninfectious surgical complications (adjusted RR, 19.38; 95% CI, 2.25-167.29). The long-term mortality rate was 11.88%. The probability of surviving at 12, 24, and 36 months was 0.94, 0.92, and 0.87, respectively. Variables significantly associated with long-term death were older age (adjusted RR, 1.08; 95% CI, 1.01-1.15), high values of creatinine on discharge (adjusted RR, 1.91; 95% CI, 1.08-3.38), and an SSI with the highest adjusted RR (6.35; 95% CI, 1.87-21.53). CONCLUSIONS: SSI was the primary NI. The risk of NI depended primarily on the presence of a lower extremity SSTI at the time of surgery, whereas mortality was determined by age, surgical complications during the operation, and SSI. These findings suggest that in those cases in which surgery is reasonably delayed, surgery should be deferred until the lower extremity SSTIs are resolved.
引用
- Fariñas MC, Campo A, Duran R, et al. Risk factors and outcomes for nosocomial infection after prosthetic vascular grafts. J Vasc Surg. 2017. PMID: 28823865. doi:10.1016/j.jvs.2017.06.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。